UPDATE 1-Forward Pharma loses appeal in Tecfidera patent dispute with Biogen
23 Oct UPDATE 1-Forward Pharma loses appeal in Tecfidera patent dispute with Biogen
Posted at 14:53h
in
News
by KMFSLLP
A U.S. federal appeals court on Wednesday
upheld a ruling that Biogen Inc’s patents on its blockbuster
multiple sclerosis drug Tecfidera are valid, rejecting a
challenge by Danish drugmaker Forward Pharma A/S.
Sorry, the comment form is closed at this time.